公开(公告)号：JP2010184948A

公开(公告)日：2010-08-26

申请号：JP2010129337

申请日：2010-06-04

Applicant: Immunomedics Inc ,  イミューノメディクス、インコーポレイテッドImmunomedics, Inc.

Inventor： GOLDENBERG MILTON DAVID

IPC: A61K39/395 ,  A61K49/00 ,  A61B5/05 ,  A61B5/055 ,  A61K45/00 ,  A61K47/48 ,  A61K49/16 ,  A61K51/04 ,  A61K51/08 ,  A61K51/10 ,  A61P35/00 ,  A61P43/00 ,  C07K20060101 ,  C07K16/18 ,  C07K16/28 ,  C07K17/00 ,  G01N33/53 ,  G01R33/28 ,  G01R33/48

CPC classification number: G01R33/5601 ,  A61K49/16 ,  A61K51/10 ,  A61K51/1018 ,  A61K51/1036 ,  A61K51/1039 ,  A61K51/1045 ,  A61K51/1057 ,  A61K51/1072 ,  A61K2123/00 ,  B82Y5/00 ,  Y10S424/81 ,  Y10S530/868

Abstract: PROBLEM TO BE SOLVED: To provide a method for treatment of conditions relating to hypoplasia, missing, anatomically substituted, or ectopic tissues or organs. SOLUTION: The method uses a medicine including an antibody or a fragment of the same formed by a non-tumorous cell or a non-tumorous tissue, or a specifically bound marker relating to the same as an active component to remove functions of the non-tumorous cell or the non-tumorous tissue, or influence the functions of a patient, wherein the antibody or the fragment thereof is conjugated with the therapeutic agent. COPYRIGHT: (C)2010,JPO&INPIT

Abstract translation: 要解决的问题：提供治疗与发育不全，缺失，解剖学取代或异位组织或器官有关的病症的方法。 解决方案：该方法使用包含由非肿瘤细胞或非肿瘤组织形成的抗体或其片段的药物，或与活性成分相关的特异性结合标记，以除去 非肿瘤细胞或非肿瘤组织，或影响患者的功能，其中抗体或其片段与治疗剂缀合。 版权所有（C）2010，JPO＆INPIT

公开(公告)号：JP2006083183A

公开(公告)日：2006-03-30

申请号：JP2005322919

申请日：2005-11-07

Applicant: Immunomedics Inc ,  イムノメディクス, インコーポレイテッド

Inventor： GOLDENBERG MILTON DAVID

IPC: A61K39/395 ,  A61K49/00 ,  A61B5/05 ,  A61B5/055 ,  A61K45/00 ,  A61K47/48 ,  A61K49/16 ,  A61K51/04 ,  A61K51/08 ,  A61K51/10 ,  A61P35/00 ,  A61P43/00 ,  C07K20060101 ,  C07K16/18 ,  C07K16/28 ,  C07K17/00 ,  G01N33/53 ,  G01R33/28 ,  G01R33/48

CPC classification number: G01R33/5601 ,  A61K49/16 ,  A61K51/10 ,  A61K51/1018 ,  A61K51/1036 ,  A61K51/1039 ,  A61K51/1045 ,  A61K51/1057 ,  A61K51/1072 ,  A61K2123/00 ,  B82Y5/00 ,  Y10S424/81 ,  Y10S530/868

Abstract: PROBLEM TO BE SOLVED: To provide a method for treating a state related to a hypoplastic, deficient, anatomically substituted, or ectopic tissue or organ.
SOLUTION: A pharmaceutical contains an antibody or an antibody fragment specifically binding to a marker which is produced by a non-tumoral cell or a non-tumoral tissue or associated with the cell or the tissue as an active ingredient, so as to remove a function of the non-tumoral cell or the non-tumoral tissue of a patient or produce an effect on the function, wherein such a pharmaceutical that the antibody or the antibody fragment conjugates with the pharmaceutical is used.
COPYRIGHT: (C)2006,JPO&NCIPI

Abstract translation: 待解决的问题：提供一种治疗与发育不全，缺陷，解剖学取代或异位组织或器官有关的状态的方法。 解决方案：药物含有特异性结合标志物的抗体或抗体片段，其由非肿瘤细胞或非肿瘤组织产生或与细胞或组织相关联作为活性成分，以便 去除患者的非肿瘤细胞或非肿瘤组织的功能，或对功能产生影响，其中使用抗体或抗体片段与药物偶联的药物。 版权所有（C）2006，JPO＆NCIPI